PT Indofarma Tbk
IDX:INAF.JK
Overview | Financials
Company Name | PT Indofarma Tbk |
Symbol | INAF.JK |
Currency | IDR |
Price | 126 |
Market Cap | 390,508,020,000 |
Dividend Yield | 0% |
52-week-range | 126 - 725 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Jejen Nugraha |
Website | https://indofarma.id |
An error occurred while fetching data.
About PT Indofarma Tbk
PT Indofarma Tbk, together with its subsidiaries, manufactures and markets pharmaceutical products in Indonesia. The company trades in and distributes drugs, medical devices, medical supplies, extracts, and herbals; and operates laboratory. It also provides COVID-19 test services, including rapid diagnostic test antigen; reverse transcription polymerase chain reaction, and genose. The
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD